Drugs News and Research

RSS

Isaiah J. Fidler earns 2013 American Cancer Society Medal of Honor for Basic Research

When Isaiah J. Fidler, D.V.M., Ph.D., left his veterinary surgical practice to pursue a doctorate that would allow him to study and combat the lethal spread of cancer to other organs, he got lots of advice. The common message: Don't go there.

30 May 2013

Research explores connections between the brain, immune system and psychological functions

It's true that the brain governs the body, but the body also governs the brain, for example when the immune defense system makes us rest when we're sick. This is shown in research that the world's leading researchers and Nobel laureates will be presenting at an international conference in the research field of psychoneuroimmunology in Stockholm in June.

30 May 2013

Ruthenium complexes could pave way for cancer treatments, say UT Arlington researchers

A team of UT Arlington researchers has identified two ruthenium-based complexes they believe could pave the way for treatments that control cancer cell growth more effectively and are less toxic for patients than current chemotherapies.

30 May 2013

Researchers examine quality of information given by sales reps when promoting drugs to physicians

Dr. Genevi-ve Durrieu (from the Pharmaco-epidemiology team assessing the use of medication and the risks involved, Unit 1027 "Epidemiology and public health analyses: risks, chronic diseases and handicaps" - Inserm / Universit- Toulouse III - Paul Sabatier) led the French part of this study, the results of which are published in the Journal of General Internal Medicine. Within the framework of this international study, is France proving to be a model student?

30 May 2013

Injectable drugs used in TPN to be imported into US, says FDA

The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition in critical shortage will be imported into the United States and available to patients this week.

30 May 2013

Scientists develop new chemical method to treat Alzheimer's disease

Scientists at the University of Liverpool and Callaghan Innovation in New Zealand have developed a new chemical approach to help harness the natural ability of complex sugars to treat Alzheimer's disease.

30 May 2013

Calif. Senate OKs measure expanding nurse practitioners' role

California lawmakers on Tuesday approved a bill that would allow nurse practitioners to practice more independently amid worries over a shortage of health care providers. The bill would allow the practitioners to have stand-alone practices, among other things.

30 May 2013

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

30 May 2013

Strengthening miniaturized titanium-based medical devices: an interview with Dr Masaru Rao, University of California, Riverside

While titanium is used widely for more conventional macro-scale medical devices (e.g. hip implants, dental implants, and cardiac pacemakers), its use for micro- and nano-scale devices has been limited thus far.

29 May 2013

Viewpoints: 'Good news' on Calif. insurance rates; Battle against dementia needs stronger efforts; Dental care for the disabled

The Affordable Care Act, a k a Obamacare, goes fully into effect at the beginning of next year, and predictions of disaster are being heard far and wide. ... No doubt there will be problems, as there are with any large new government initiative, and in this case, we have the added complication that many Republican governors and legislators are doing all they can to sabotage reform. Yet important new evidence - especially from California, the law's most important test case - suggests that the real Obamacare shock will be one of unexpected success (Paul Krugman, 5/26).

29 May 2013

EMA grants Sucampo orphan drug designation for unoprostone isopropyl to treat retinitis pigmentosa

Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment of retinitis pigmentosa (RP). RP is a genetic disease characterized by progressive, irreversible vision loss and decreasing visual acuity, and there are no drugs or therapeutic procedures currently approved for the treatment of RP today.

29 May 2013

Spherical nanoparticles transform into netlike structures at site of cancer

Scientists at the University of California, San Diego, have designed tiny spherical particles to float easily through the bloodstream after injection, then assemble into a durable scaffold within diseased tissue. An enzyme produced by a specific type of tumor can trigger the transformation of the spheres into netlike structures that accumulate at the site of a cancer, the team reports in the journal Advanced Materials this week.

29 May 2013

Researchers to examine effectiveness of antibiotic therapy to treat appendicitis in children

In the first study of its kind in the United States, researchers at Nationwide Children's Hospital will examine the effectiveness of antibiotic therapy alone to treat appendicitis in children, research that could allow patients to avoid a surgery many may not need.

29 May 2013

Research sheds new light on the increasing use of prescription drugs among young people

Young people are increasingly turning to prescription drugs to get high. Research out of the University of Cincinnati sheds new light on what could increase or lower that risk.

29 May 2013

Columbia University, Chinese Center for Disease Control to open joint pathogen discovery lab in Beijing

The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.

29 May 2013

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

29 May 2013

Businesses brace for health law's coverage requirements, potential costs

Some large companies are scaling back generous health plans they have traditionally offered employees, even though the so-called 'Cadillac tax' on high-end plans doesn't take effect until 2018, while small firms are exploring early coverage renewals and self-insurance.

29 May 2013

Drugs News and Research

Isaiah J. Fidler earns 2013 American Cancer Society Medal of Honor for Basic Research

Research explores connections between the brain, immune system and psychological functions

Ruthenium complexes could pave way for cancer treatments, say UT Arlington researchers

Researchers examine quality of information given by sales reps when promoting drugs to physicians

Injectable drugs used in TPN to be imported into US, says FDA

Scientists develop new chemical method to treat Alzheimer's disease

Calif. Senate OKs measure expanding nurse practitioners' role

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

Strengthening miniaturized titanium-based medical devices: an interview with Dr Masaru Rao, University of California, Riverside

Viewpoints: 'Good news' on Calif. insurance rates; Battle against dementia needs stronger efforts; Dental care for the disabled

EMA grants Sucampo orphan drug designation for unoprostone isopropyl to treat retinitis pigmentosa

Spherical nanoparticles transform into netlike structures at site of cancer

Researchers to examine effectiveness of antibiotic therapy to treat appendicitis in children

Research sheds new light on the increasing use of prescription drugs among young people

Columbia University, Chinese Center for Disease Control to open joint pathogen discovery lab in Beijing

Research discovery may lead to development of new therapies for neurological disorders

Businesses brace for health law's coverage requirements, potential costs

New approach to battle prostate cancer

Consumption of illegal drugs, abusive intake of soda can damage teeth

UT Southwestern researchers develop new class of drugs for prostate cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News